Clinical efficacy of non steroidal antiphlogistica in acute mastitis;Klinische wirksamkeit nicht steroidaler antiphlogistika beim vorliegen akuter mastitiden

Praktische Tierarzt

Volumn 84, Issue 5, 2003, Pages 390-396

  Hamann, J ^a   Friton, Gabriele M ^b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Acute clinical mastitis; Field study; Flunixin; Meloxicam; Non steroidal antiphlogistica; Therapy

Indexed keywords

ANTIBIOTIC AGENT; FLUNIXIN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL WELFARE; CONFERENCE PAPER; CONTROLLED STUDY; COW; DAIRYING; DOUBLE BLIND PROCEDURE; ECONOMIC ASPECT; EPIDEMIOLOGICAL DATA; EVALUATION; MASTITIS; MILK LEVEL; NONHUMAN; RANDOMIZATION;

ANIMALIA;

EID: 0037715067     PISSN: 0032681X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. ANDERSON, K. L.: Nichtsteroidale Antiphlogistika des Rindes zur Behandlung der akuten Kolimastitis. Prakt. Tierarzt 2, 111-121 (1991).
2. ANDERSON, K. L., A. R. SMITH, R. D. SHANKS, L. E. DAVIS und B. K. GUSTAFSSON: Efficacy of flunixin meglumine for the treatment of endotoxin-induced bovine mastitis. Am. J. Vet. Res. Jun. 47 (6), 1366-1372 (1986).
3. ANDERSON, K. L. und E. HUNT: Anti-infammatory therapy in acute endotoxin-induced bovine mastitis. Veterinary Research Communications, 13: 17-26 (1989).
4. th International Congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT), Jerusalem, Israel, July 30-August 3 (2000).
5. CEBRA, C. K., F. B. GARRY und R. P. DINSMORE: Naturally occurring acute coliform mastitis in Holstein cattle. Journal of Vet. Internal med., Vol. 10, 4, 252-257 (1996).
6. DASCANIO, J. J., G. D. MECHOR, Y. T. GRÖHN, D. G. KENNEY, C. A. BOOKER, P. THOMPSON, C. L. CHIFFELLE, J. M. M. MUSSER und L. D. WARNICK: Effect of phenylbutazone and flunixin meglumine on acute toxic mastitis in dairy cows. Am. J. Vet. Res. Vol. 56. September (1995).
7. DODD, F. H.: The role of therapy in mastitis control. Proc. Int. Symp. Mastitis, Quebec (Canada). 161-175 (1987).
8. ERSKINE, R. J., J. H. KIRK, J.W. TYLER und F. J. DEGRAVES: Advances in the therapy for mastitis. Veterinary Clinics of North America, Food Animal Practice 9: 499-517 (1993).
9. FABRE, J. M., X. BERTHELOT, P. LEBRET, M. F. BLANC und M. C. BLANC: Estimation of the frequency of different bacterial agents of mammary infections in dairy herds in southwestern France. Revenue de Medecine Veterinaire 142 (11): 823-829 (1991).
10. HAMANN, J.: Zum Kosten-Nutzen-Verhältnis der antibiotischen Mastitistherapie. Prakt. Tierarzt, coll. vet. XXIX, 44-47 (1999).
11. HAMANN, J.: Zur medikamentösen Therapie boviner Mastitiden - Einordnung und Bewertung. Prakt. Tierarzt 10 (1989).
12. LAMMERS, A., C.J. VANVORSTENBOSCH, J. H. ERKENS und H. E. SMITH: The major bovine mastitis pathogens have different cell tropisms in culture of bovine mammary cells. Vet. Microbiol. 2001 Jun 6, 80 (3): 255-265 (2001).
13. LOHUIS, J. A. C. M., W. VAN LEEUWEN, J. H. M. VERHEIJDEN, A. BRAND und V. S. VAN MIERT: Effect of steroidal anti-inflammatory drugs on Escherichia coli endotoxin-induced mastitis in the cow. J. Dairy Sci. 72: 241-249 (1989).
14. MATSUNAGA, T., S. KAMATA, N. KAKIICHI und K. UCHIDA: Characteristics of Staphylococcus aureus: Variability of the target cells and 2 pharmacological processes. Pathol. Biol. (Paris), Jun., Vol. 46 (6), 435-441 (1998).
15. MILTENBURG, J. D., D. DE LANGE, A. P. P. CRAUWELS, J. H. BONGERS, M. J. M. TIELEN, Y. H. SCHUKKEN und A. R. W. ELBERS: Incidence of clinical mastitis in a random sample of dairy herds in the southern Netherlands. Vet. Rec. 139, p. 204-207 (1996).
16. MORKOC, A. C., W. L. HURLEY, H. L. WHITEMORE und B. K. GUSTAFSSON: Bovine acute mastitis: effects of intravenous sodium salicylate on endotoxin-induced intramammary inflammation. J. Dairy Sci. Sep, 76 (9): 2579-2588 (1993).
17. PREVOST, G., D. A. COLIN, L. STAALI, L. BABAMOUSSA, A. GRAVET, S. WERNER, A. SANNI, O. MEUNIER und H. MONTEIL: Pore-forming leukotoxins from Staphyococcus aureus: Variability of the target cells and 2 pharmacological processes. Pathol. Biol. (Paris) Jun, Vol. 46 (6), 435-441 (1998).
18. SAS®-SYSTEM SAS/STAT: User's Guide. Release 6.12 Edition. SAS Institute Inc. Cary, North Carolina, (1998).
19. SANDHOLM, M.: Alternative to antimicrobials in mastitis therapy. Proc. Eur. Assoc. Vet. Pharmacol. Toxicol., 6 Met., 90-92 (1994).
20. SHPIGEL, N. Y., R. CHEN, M. WINKLER, A. SARAN, G. ZIV und F. LONGO: Anti-inflammatory ketoprofen in the treatment of field cases of bovine mastitis. Research in Veterinary Science 56: 62-68 (1994).
21. SHPIGEL, N. Y., M. WINKLER, G. ZIV und A. SARAN: Clinical, bacteriological and epidemiological aspects of clinical mastitis in Israeli dairy herds. Preventive Veterinary Medicine 35, p. 1-9 (1998).
22. VAN GOOL, E, F. LONGO und O. SALAT: Incidence of clinical mastitis in French dairy herds epidemiological data and economic costs. Proceedings of the Symposium on Immunology of the Ruminant Mammary Gland, Stresa, 11-14 June, pp. 391-392 (2000).
23. WENZ, J. R., G. M. BARRINGTON, F. B. GARRY, K. D. McSWEENEY, R. P. DINSMORE, G. GOODELL und R. J. CALLAN: Bacteriemia associated with naturally occuring acute coliform mastitis in dairy cows. J. Am. Vet. Med. Ass., Vol. 219, No. 7, October 1 (2001).
24. ZIV, G: Treatment of peracute and acute mastitis. Veterinary Clinics of North America: Food Animal Practice. Vol. 8. No. 1 (1992).